Skip to content

13F-HR filed by QVT Financial LP

QVT Financial LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 34 holding rows worth $1,063,387,574.

Accession
0000950123-24-008706
Filed
2024-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, 34 entries on the cover page, a total value of $1,063,387,574 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,063,387,574 with VALUE read as dollars as filed, 13F file number 028-11172. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ROIVANT SCIENCES LTDG76279101SHS66,719,779$705,228,064dollars as filed
MP MATERIALS CORP553368101COM CL A3,494,158$44,480,631dollars as filed
OKEANIS ECO TANKERS COR SHSY64177101Stock1,423,997$41,190,537dollars as filed
Goldman Sachs Group,Inc.38141G104COM73,833$33,396,143dollars as filed
NEXSTAR MEDIA GROUP INC COMMON STOCK65336K103Stock165,735$27,513,667dollars as filed
NELNET INC64031N108CL A229,665$23,164,012dollars as filed
ANTERIX INC03676C100COMMON STOCK503,941$19,951,024dollars as filed
Berkshire Hathaway Inc084670702COM47,946$19,504,433dollars as filed
LIBERTY LATIN AMERICA LTDG9001E128COM CL C1,749,467$16,829,873dollars as filed
NEW YORK TIMES CO MTN BE CL A650111107Stock316,947$16,230,856dollars as filed
MAKEMYTRIP LIMITED MAURITIUS SHSV5633W109Stock191,632$16,116,251dollars as filed
MAKEMYTRIP LIMITED MAURITIUS56087FAB0NOTE 2/16,500,000$14,344,615dollars as filedprincipal
ARGENX SE SPONSORED ADR04016X101ADR32,498$13,975,440dollars as filed
SEA LTD81141RAG5NOTE 0.250% 9/115,000,000$13,105,573dollars as filedprincipal
Tourmaline Bio Inc89157D105Common Stock711,275$9,146,996dollars as filed
NIO INC62914VAF3NOTE 0.500% 2/08,500,000$8,065,201dollars as filedprincipal
ALLOT LTDM0854Q105SHS2,857,225$6,628,762dollars as filed
BIOHAVEN LTDG1110E107COM170,006$5,900,908dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM678,564$5,442,083dollars as filed
SUMMIT THERAPEUTICS INC86627T108COM575,705$4,490,499dollars as filed
VERTEX ENERGY INC92534K107COM4,125,000$3,896,888dollars as filed
H World Group Ltd44332NAB2Convertible bond2,000,000$2,942,871dollars as filedprincipal
INFORMATICA INC45674M101COM CL A90,817$2,804,429dollars as filed
BILIBILI INC090040AF3NOTE 0.500%12/02,600,000$2,520,646dollars as filedprincipal
NETEASE COM INC SPONSORED ADS64110W102ADR21,394$2,044,839dollars as filed
GRAY MEDIA INC389375106COMMON STOCK291,452$1,515,550dollars as filed
JD.COM INC SPON ADS CL A47215P106ADR32,274$833,960dollars as filed
SAREPTA THERAPEUTICS INC803607100COM3,117$492,486dollars as filed
VERTEX ENERGY INC92534K107COM500,000$472,350dollars as filedcall
BIOMARIN PHARMACEUTICAL INC09061G101COM4,429$364,640dollars as filed
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS4,813$346,536dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM19,613$318,711dollars as filed
Mersana Therapeutics Inc59045L106Common Stock62,657$125,941dollars as filed
BOA ACQUISITION CORPg8059b119WT144,913$2,159dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-008706this filing2024-08-14acceptance time not in the bulk data set